GLOO trades 171.9% below Wall Street's consensus target of $12.75.
Last 12 months price action with 12-month analyst target path
The base valuation assumes GLOO achieves its forward estimates and maintains a stable P/E multiple of historical averagesx. This scenario reflects the blended consensus of 2 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 22, 2026, Gloo Holdings, Inc. (GLOO) has a Wall Street consensus price target of $12.75, based on estimates from 2 covering analysts. With the stock currently trading at $4.69, this represents a potential upside of +171.9%. The company has a market capitalization of $379M.
Analyst price targets range from a low of $10.00 to a high of $17.00, representing a 55% spread in expectations. The median target of $12.00 differs from the mean, suggesting potential outlier estimates. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Buy, with 2 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, GLOO trades at a trailing P/E of -2.1x. Analysts expect EPS to grow -409.7% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
HIMSHims & Hers Health, Inc. | $7.8B | $35.47 | $28.08 | -20.8% | Hold | — | 20 |
ACMRACM Research, Inc. | $7.3B | $109.87 | $100.00 | -9.0% | Buy | 55.2x | 10 |
EVEREverQuote, Inc. | $713M | $20.16 | $22.75 | +12.8% | Buy | 9.6x | 13 |
CXAICXApp Inc. | $6M | $0.26 | — | — | — | — | — |
BRZEBraze, Inc. | $2.3B | $20.06 | $34.17 | +70.3% | Buy | 31.7x | 25 |
PLTKPlaytika Holding Corp. | $1.3B | $3.49 | $3.50 | +0.3% | Hold | 8.1x | 17 |
TWLOTwilio Inc. | $28.2B | $186.17 | $197.08 | +5.9% | Buy | 32.6x | 52 |
HUBSHubSpot, Inc. | $9.0B | $176.03 | $285.14 | +62.0% | Buy | 13.4x | 47 |
APPSDigital Turbine, Inc. | $1.0B | $8.61 | $32.50 | +277.5% | Buy | 21.8x | 11 |
CLOVClover Health Investments, Corp. | $2.6B | $5.00 | $4.47 | -10.6% | Hold | 129.2x | 9 |
Quick answers to the most common questions about buying GLOO stock.
The consensus Wall Street price target for GLOO is $12.75, representing 171.9% upside from the current price of $4.69. With 2 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
GLOO has a consensus rating of "Buy" based on 2 Wall Street analysts. The rating breakdown is predominantly bullish, with 2 Buy/Strong Buy ratings. The consensus 12-month price target of $12.75 implies 171.9% upside from current levels.
GLOO's current price is $4.69 with a consensus target of $12.75 (171.9% implied move). Analyst estimates suggest the stock is undervalued at current levels.
The most bullish Wall Street analyst has a price target of $17 for GLOO, while the most conservative target is $10. The consensus of $12.75 represents the median expectation. These targets typically reflect 12-month expectations.
GLOO is lightly followed, with 2 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 2 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month GLOO stock forecast based on 2 Wall Street analysts shows a consensus price target of $12.75, with estimates ranging from $10 (bear case) to $17 (bull case). The median consensus rating is "Buy".
Wall Street analysts are very optimistic on GLOO, with a "Buy" consensus rating and $12.75 price target (171.9% upside). 2 of 2 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
GLOO analyst price targets range from $10 to $17, a 55% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $12.75 consensus represents the middle ground.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.